|
Originally published In Press as doi:10.1074/jbc.M200218200 on March 8, 2002
J. Biol. Chem., Vol. 277, Issue 21, 18860-18867, May 24, 2002
Identification of STAT-1 as a Molecular Target of IGFBP-3
in the Process of Chondrogenesis*
Anna
Spagnoli §¶,
Monica
Torello§ ,
Srivinasa R.
Nagalla**,
William A.
Horton ,
Patrick
Pattee**,
Vivian
Hwa**,
Francesco
Chiarelli ,
Charles T.
Roberts Jr.**, and
Ron G.
Rosenfeld**
From the Department of Pediatrics, Vanderbilt
University Medical Center, Nashville, Tennessee 37232-2579, the
Research Center, Shriners Hospital for Children, Portland,
Oregon 97201, the ** Department of Pediatrics, Oregon
Health & Science University, Portland, Oregon 97201, and the
 Department of Pediatrics, University of
Chieti, Chieti 66013, Italy
The chondrogenesis process requires
the ordered proliferation and differentiation of chondrocytes.
Insulin-like growth factor-binding protein (IGFBP)-3, well
characterized as the carrier of insulin-like growth factor (IGF), has
been reported to have intrinsic bioactivity that is independent of IGF
binding. The mechanisms involved in this IGF-independent action are
still unclear. Using the RCJ3.1C5.18 chondrogenic cells, which in
culture progresses from undifferentiated to terminally differentiated
chondrocytes, we have shown previously that IGFBP-3 has an
IGF-independent, antiproliferative effect in undifferentiated and early
differentiated but not in terminally differentiated chondrocytes. In
the present study, cDNA microarray analysis was used to screen for
genes: 1) that were regulated by IGFBP-3 in early but not in terminally
differentiated chondrocytes; 2) that were regulated specifically by
IGFBP-3, but not by IGF-I; and 3) whose regulation was abolished by
coincubation of IGFBP-3 with IGF-I. Signal transducer and activator of
transcription (STAT)-1 was the gene that, fulfilling the screening
criteria, exhibited the greatest up-regulation by IGFBP-3 (>40-fold).
STAT-1 gene up-regulation was confirmed by Northern analysis of cells
treated with IGFBP-3 or transfected with an IGFBP-3 expression vector. Remarkably, similar results were obtained when cells were transfected with an IGFBP-3 mutant unable to bind IGFs, definitively demonstrating the IGF-independent action of IGFBP-3. Consistent with the
up-regulation of STAT-1 mRNA, IGFBP-3 also increased STAT-1 protein
expression. Furthermore, both IGFBP-3 and the IGFBP-3 mutant induced
STAT-1 phosphorylation and its nuclear localization. An antisense
STAT-1 oligonucleotide abolished the IGF-independent cell apoptosis
induced by IGFBP-3. We have demonstrated that STAT-1 is a major
intracellular signaling and transcriptional target of the
IGF-independent apoptotic effect of IGFBP-3 in chondrogenesis.
*
This work was supported in part by grant from the Medical
Research Foundation of Oregon (to A. S.). This work was presented in part at the 83rd Annual Meeting of the Endocrine
Society, Denver, June 2001 and the 6th Joint Meeting of the
Lawson-Wilkins Pediatric Endocrine Society and European Society
for Paediatric Endocrinology, Montreal, Canada, July 2001.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
These authors contributed equally to this work.
¶
To whom correspondence should be addressed: Dept. of
Pediatrics, Vanderbilt University Medical Center, T-0107 Medical Center North, Nashville, TN 37232-2579. E-mail:
anna.spagnoli@mcmail.vanderbilt.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. M. Yamada and K.-W. Lee
Perspectives in mammalian IGFBP-3 biology: local vs. systemic action
Am J Physiol Cell Physiol,
May 1, 2009;
296(5):
C954 - C976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Y. Chan, L. J. Schedlich, S. M. Twigg, and R. C. Baxter
Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3
Am J Physiol Endocrinol Metab,
April 1, 2009;
296(4):
E654 - E663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Zappala, C. Elbi, J. Edwards, J. Gorenstein, M. M. Rechler, and N. Bhattacharyya
Induction of Apoptosis in Human Prostate Cancer Cells by Insulin-Like Growth Factor Binding Protein-3 Does Not Require Binding to Retinoid X Receptor-{alpha}
Endocrinology,
April 1, 2008;
149(4):
1802 - 1812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Iosef, T. Gkourasas, C. Y. H. Jia, S. S.-C. Li, and V. K. M. Han
A Functional Nuclear Localization Signal in Insulin-Like Growth Factor Binding Protein-6 Mediates Its Nuclear Import
Endocrinology,
March 1, 2008;
149(3):
1214 - 1226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Zaman, V. Menendez-Benito, E. Eriksson, A. S. Chagin, M. Takigawa, B. Fadeel, N. P. Dantuma, D. Chrysis, and L. Savendahl
Proteasome Inhibition Up-regulates p53 and Apoptosis-Inducing Factor in Chondrocytes Causing Severe Growth Retardation in Mice
Cancer Res.,
October 15, 2007;
67(20):
10078 - 10086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, M. Zhou, J. Brand, and L. Huang
Inflammation Activates the Interferon Signaling Pathways in Taste Bud Cells
J. Neurosci.,
October 3, 2007;
27(40):
10703 - 10713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-W. Lee, L. J. Cobb, V. Paharkova-Vatchkova, B. Liu, J. Milbrandt, and P. Cohen
Contribution of the orphan nuclear receptor Nur77 to the apoptotic action of IGFBP-3
Carcinogenesis,
August 1, 2007;
28(8):
1653 - 1658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bhattacharyya, K. Pechhold, H. Shahjee, G. Zappala, C. Elbi, B. Raaka, M. Wiench, J. Hong, and M. M. Rechler
Nonsecreted Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Can Induce Apoptosis in Human Prostate Cancer Cells by IGF-independent Mechanisms without Being Concentrated in the Nucleus
J. Biol. Chem.,
August 25, 2006;
281(34):
24588 - 24601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Burrows, J. M. P. Holly, N. J. Laurence, E. G. Vernon, J. V. Carter, M. A. Clark, J. McIntosh, C. McCaig, Z. E. Winters, and C. M. Perks
Insulin-Like Growth Factor Binding Protein 3 Has Opposing Actions on Malignant and Nonmalignant Breast Epithelial Cells that Are Each Reversible and Dependent upon Cholesterol-Stabilized Integrin Receptor Complexes
Endocrinology,
July 1, 2006;
147(7):
3484 - 3500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Takaoka, C. E. Smith, M. K. Mashiba, T. Okawa, C. D. Andl, W. S. El-Deiry, and H. Nakagawa
EGF-mediated regulation of IGFBP-3 determines esophageal epithelial cellular response to IGF-I
Am J Physiol Gastrointest Liver Physiol,
February 1, 2006;
290(2):
G404 - G416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L O'Rear, L Longobardi, M Torello, B K Law, H L Moses, F Chiarelli, and A Spagnoli
Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-{beta} in mesenchymal chondroprogenitor cell growth
J. Mol. Endocrinol.,
June 1, 2005;
34(3):
723 - 737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Longobardi, M. Torello, C. Buckway, L. O'Rear, W. A. Horton, V. Hwa, C. T. Roberts Jr., F. Chiarelli, R. G. Rosenfeld, and A. Spagnoli
A Novel Insulin-Like Growth Factor (IGF)-Independent Role for IGF Binding Protein-3 in Mesenchymal Chondroprogenitor Cell Apoptosis
Endocrinology,
May 1, 2003;
144(5):
1695 - 1702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Firth and R. C. Baxter
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Endocr. Rev.,
December 1, 2002;
23(6):
824 - 854.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|